{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:09:43Z","timestamp":1790676583846,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Priority Academic Program Development of Jiangsu Higher Education Institutions, National Natural Science Foundation of China","award":["81370614"],"award-info":[{"award-number":["81370614"]}]},{"name":"Sci-tech Innovation Team of Jiangsu Province","award":["LJ201116"],"award-info":[{"award-number":["LJ201116"]}]},{"name":"Natural Science Foundation of Jiangsu Province, China","award":["BK2011486"],"award-info":[{"award-number":["BK2011486"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170279"],"award-info":[{"award-number":["81170279"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Laboratory of Cardiovascular Disease of Zhenjiang","award":["SS2012002"],"award-info":[{"award-number":["SS2012002"]}]},{"name":"Graduate Innovation Foundation of Jiangsu Province, China","award":["CXZZ13_0702"],"award-info":[{"award-number":["CXZZ13_0702"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.clim.2015.05.017","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T03:13:13Z","timestamp":1434165193000},"page":"198-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome"],"prefix":"10.1016","volume":"160","author":[{"given":"Hongxiang","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yachao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangju","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2015.05.017_bb0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2015.05.017_bb0010","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2015.05.017_bb0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/nyas.12080","article-title":"Anti-beta2-glycoprotein I antibodies","volume":"1285","author":"Willis","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.clim.2015.05.017_bb0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MOH.0000000000000067","article-title":"Recent advances in the antiphospholipid antibody syndrome","volume":"21","author":"Chaturvedi","year":"2014","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.clim.2015.05.017_bb0025","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y","article-title":"Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype","volume":"44","author":"Meroni","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2015.05.017_bb0030","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/01.CIR.99.15.1997","article-title":"Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo","volume":"99","author":"Pierangeli","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.clim.2015.05.017_bb0035","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1749-6632.2009.04632.x","article-title":"In vitro effects of antiphospholipid syndrome-IgG fractions and human monoclonal antiphospholipid IgG antibody on human umbilical vein endothelial cells and monocytes","volume":"1173","author":"Clemens","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.clim.2015.05.017_bb0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1191\/0961203305lu2048oa","article-title":"Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies","volume":"14","author":"Forastiero","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2015.05.017_bb0045","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/annrheumdis-2013-203622","article-title":"A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients","volume":"73","author":"Erkan","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2015.05.017_bb0050","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1538-7836.2007.02680.x","article-title":"Role of p38 mitogen-activated protein kinase in antiphospholipid antibody-mediated thrombosis and endothelial cell activation","volume":"5","author":"Vega-Ostertag","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2015.05.017_bb0055","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.21009","article-title":"Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies","volume":"52","author":"Vega-Ostertag","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2015.05.017_bb0060","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1160\/TH12-09-0655","article-title":"Both NF-kappaB and c-Jun\/AP-1 involved in anti-beta2GPI\/beta2GPI-induced tissue factor expression in monocytes","volume":"109","author":"Xia","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.clim.2015.05.017_bb0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood-2009-03-206367","article-title":"{beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome","volume":"115","author":"Sikara","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clim.2015.05.017_bb0070","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/art.21968","article-title":"Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V","volume":"54","author":"Shi","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2015.05.017_bb0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1538-7836.2007.02310.x","article-title":"Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2\u2032","volume":"5","author":"Pennings","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2015.05.017_bb0080","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood-2004-09-3387","article-title":"IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis","volume":"105","author":"de Laat","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clim.2015.05.017_bb0085","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2005-05-1943","article-title":"Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change","volume":"107","author":"de Laat","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clim.2015.05.017_bb0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.autrev.2012.05.006","article-title":"Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome","volume":"12","author":"Mahler","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2015.05.017_bb0095","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood-2009-12-260976","article-title":"Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome","volume":"116","author":"Agar","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clim.2015.05.017_bb0100","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1002\/art.30633","article-title":"Immune responses against domain I of beta(2)-glycoprotein I are driven by conformational changes: domain I of beta(2)-glycoprotein I harbors a cryptic immunogenic epitope","volume":"63","author":"de Laat","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2015.05.017_bb0105","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1182\/blood-2004-05-1708","article-title":"Annexin A2 mediates endothelial cell activation by antiphospholipid\/anti-beta2 glycoprotein I antibodies","volume":"105","author":"Zhang","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clim.2015.05.017_bb0110","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3892\/ijmm_00000265","article-title":"Annexin A2 mediates anti-beta 2 GPI\/beta 2 GPI-induced tissue factor expression on monocytes","volume":"24","author":"Zhou","year":"2009","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.clim.2015.05.017_bb0115","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1182\/blood-2008-11-188698","article-title":"Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo","volume":"114","author":"Romay-Penabad","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clim.2015.05.017_bb0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/bjh.12587","article-title":"The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity","volume":"164","author":"Xie","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clim.2015.05.017_bb0125","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1177\/0961203314536479","article-title":"Toll-like receptor 4 and beta2 glycoprotein I interaction on endothelial cells","volume":"23","author":"Borghi","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2015.05.017_bb0130","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/ard.2006.065037","article-title":"Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies","volume":"66","author":"Pierangeli","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2015.05.017_bb0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.thromres.2008.03.015","article-title":"Lipopolysaccharide augments venous and arterial thrombosis in the mouse","volume":"123","author":"Wang","year":"2008","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clim.2015.05.017_bb0140","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/j.1538-7836.2011.04287.x","article-title":"Towards a standardization of the murine ferric chloride-induced carotid arterial thrombosis model","volume":"9","author":"Owens","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2015.05.017_bb0145","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.thromres.2013.09.039","article-title":"Anti-beta2GPI\/beta2GPI stimulates activation of THP-1 cells through TLR4\/MD-2\/MyD88 and NF-kappaB signaling pathways","volume":"132","author":"Zhou","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clim.2015.05.017_bb0150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.molimm.2012.08.012","article-title":"Anti-beta(2)GPI\/beta(2)GPI induced TF and TNF-alpha expression in monocytes involving both TLR4\/MyD88 and TLR4\/TRIF signaling pathways","volume":"53","author":"Xie","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.clim.2015.05.017_bb0155","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/0961203309360810","article-title":"Role of tissue factor in thrombosis in antiphospholipid antibody syndrome","volume":"19","author":"Boles","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2015.05.017_bb0160","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1182\/blood-2010-08-300715","article-title":"Beta(2)-glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model","volume":"117","author":"Arad","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clim.2015.05.017_bb0165","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","article-title":"Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor","volume":"106","author":"Fischetti","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clim.2015.05.017_bb0170","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/08830185.2013.774391","article-title":"Pathogen recognition receptors: ligands and signaling pathways by Toll-like receptors","volume":"32","author":"Sasai","year":"2013","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.clim.2015.05.017_bb0175","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1111\/j.1582-4934.2010.01127.x","article-title":"Endogenous Toll-like receptor ligands and their biological significance","volume":"14","author":"Yu","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.clim.2015.05.017_bb0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/ker257","article-title":"Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis","volume":"51","author":"Goh","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2015.05.017_bb0185","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1189\/jlb.0310126","article-title":"Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis","volume":"88","author":"Huang","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2015.05.017_bb0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.0105-2896.2005.00239.x","article-title":"Toll-like receptors, endogenous ligands, and systemic autoimmune disease","volume":"204","author":"Rifkin","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2015.05.017_bb0195","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jbspin.2010.09.005","article-title":"Role for Toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus","volume":"78","author":"Richez","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.clim.2015.05.017_bb0200","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1538-7836.2011.04327.x","article-title":"Beta(2)-glycoprotein I: evolution, structure and function","volume":"9","author":"de Groot","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2015.05.017_bb0205","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.thromres.2012.08.269","article-title":"Conformation of beta2glycoprotein I and its effect on coagulation","volume":"130","author":"Ninivaggi","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clim.2015.05.017_bb0210","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood-2009-01-199117","article-title":"Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies","volume":"114","author":"Seshan","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clim.2015.05.017_bb0215","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1182\/blood-2011-03-344671","article-title":"A novel pathway for human endothelial cell activation by antiphospholipid\/anti-beta2 glycoprotein I antibodies","volume":"119","author":"Allen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clim.2015.05.017_bb0220","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.4049\/jimmunol.0902765","article-title":"Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways","volume":"184","author":"Lambrianides","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.05.017_bb0225","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev-physiol-042210-121137","article-title":"Role of tissue factor in venous thrombosis","volume":"73","author":"Manly","year":"2011","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.clim.2015.05.017_bb0230","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1160\/TH09-11-0771","article-title":"Tissue factor and thrombosis: the clot starts here","volume":"104","author":"Owens","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.clim.2015.05.017_bb0235","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/blood-2011-09-378851","article-title":"Autoantibodies specific to a peptide of beta2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes","volume":"120","author":"Colasanti","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clim.2015.05.017_bb0240","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2008.11.002","article-title":"Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis: report of a family with multiple anti-phospholipid positive members","volume":"32","author":"De Angelis","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2015.05.017_bb0245","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1182\/blood-2010-11-316158","article-title":"Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies","volume":"117","author":"Satta","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clim.2015.05.017_bb0250","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1002\/art.38785","article-title":"Role of Toll-like receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome","volume":"66","author":"Benhamou","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2015.05.017_bb0255","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/01.RES.88.2.245","article-title":"Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin","volume":"88","author":"Pierangeli","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.clim.2015.05.017_bb0260","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1046\/j.1538-7836.2003.00119.x","article-title":"E-selectin mediates pathogenic effects of antiphospholipid antibodies","volume":"1","author":"Espinola","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2015.05.017_bb0265","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2014.03.001","article-title":"Beta2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis","volume":"55","author":"Raschi","year":"2014","journal-title":"J. Autoimmun."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615002028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615002028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T21:53:44Z","timestamp":1537566824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661615002028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1521661615002028"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2015.05.017","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2015.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}